Clinical Trial Update: Assessment of Intranasal Glucagon on Endogenous Glucose Production [Phase 1]

View source ↗

Summary

Phase 1 clinical trial conducted by University Health Network in Toronto evaluating intranasal glucagon on endogenous glucose production in diabetes; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• intranasal glucagon (glucagon)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Diabetes | Phase 1 | Status: COMPLETED